ibopamine has been researched along with enalapril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Ahn, S; Benedict, CR; Donckier, J; Galanti, L; Ketelslegers, JM; Kinan, D; Konstam, MA; Melin, J; Pouleur, H; Rousseau, MF | 1 |
1 trial(s) available for ibopamine and enalapril
| Article | Year |
|---|---|
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
Topics: Aged; Coronary Disease; Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Receptors, Dopamine; Ventricular Function, Left | 1994 |
1 other study(ies) available for ibopamine and enalapril
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |